Ramachandran, S, Bhartia, M, Jones, A and Strange, RC (2019) PCSK9 Inhibitors in Diabetic Dyslipidemia. In: RSSDI Diabetes Update 2018. J P Medical Publishers, pp. 374-378. ISBN 978-93-5270-618-1

[thumbnail of RSSDI PCSK9 Inhibitors in Diabetic Dyslipidemia 28082018rcs.docx] Text
RSSDI PCSK9 Inhibitors in Diabetic Dyslipidemia 28082018rcs.docx - Accepted Version

Download (190kB)


The association between cardiovascular disease (CVD) risk and raised serum total cholesterol (TC) and low density lipoprotein-cholesterol (LDL-C) has been demonstrated in epidemiology1 and intervention trials showing significant decreases in CVD following use of LDL-C reducing agents such as statins and ezetimibe and has given rise to the LDL hypothesis2. However, even with statin / ezetimibe combination treatment, many patients fail to achieve lipid reduction targets. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are monoclonal antibodies that bind and inactivate PCSK9, leading to decreased LDL receptor degradation and hence enhanced LDL receptor recycling back to the liver surface (up to 150 times) and increased LDL uptake3. PCSK9 inhibition was identified as a potential modifier of CVD risk as loss of function mutations in the PCSK9 gene?? were associated with low LDL-C and reduced CVD4, We will explore efficacy (trials and in an out-patient setting) and outcome evidence with emphasis on patients with diabetes (DM) especially type 2 diabetes (T2DM).

Item Type: Book Section
Additional Information: The final version of this article is found published in a book, with the relative information online, which can be found with all relevant information on the publishers site. This can be found in the following places; http://www.jpmedpub.com/bookdetails.aspx?SearchTxt=diabetes%20update&OBookID=2838 https://jaypee.ciplamed.com/book/9789352706181/chapter/ch76 jaypeebrothers.com jaypeedigital.com
Subjects: R Medicine > RC Internal medicine
R Medicine > RC Internal medicine > RC660 Diabetes
R Medicine > RC Internal medicine > RC666 Diseases of the circulatory (Cardiovascular) system
Divisions: Faculty of Medicine and Health Sciences > Institute for Science and Technology in Medicine
Related URLs:
Depositing User: Symplectic
Date Deposited: 26 Sep 2018 09:52
Last Modified: 09 Sep 2020 13:18
URI: https://eprints.keele.ac.uk/id/eprint/5344

Actions (login required)

View Item
View Item